October 10, 2019

OncoSec Medical Stock Another Victim of Chinese Aggression

OncoSec Medical stock is just the most recent victim of Chinese business practices that violate WTO rules. OncoSec wants to sell its TAVO product in China. In order to do...

by Lance Jepsen

Stocks To Watch

October 6, 2019

De-risking Across Entire Portfolio For This Company

This company has an entire portfolio of drugs that are based on the same biotechnology that was confirmed last week with clinical tra... SUBSCRIBE OR SIGN IN

by Lance Jepsen

Stock Trading

September 30, 2019

SGEN Stock Pops After Stealing the Show

SGEN stock has popped after reports that Seattle Genetics stole the show at ESMO. Stifel analyst Stephen Willey, said in a note called “EV-103 Data Steals the ESMO...

by Lance Jepsen

Stocks To Watch

September 11, 2019

DTIL Stock Bottom Feeder Play

DTIL stock took a big bounce off what could be a bottom in the stock after the company announced a new in-house manufacturing facility in the U.S. Precision BioSciences opened...

by Lance Jepsen

Stock Trading

September 5, 2019

AUTL Stock Bounces After Nature Medicine Data

AUTL stock bounced after the company released VERY positive data from a clinical trial on September 5, 2019. Autolus Therapeutics plc (AUTL), a clinical-stage...

by Lance Jepsen

Stock Trading

August 21, 2019

CHRS Stock Moving Higher On Two Investor Healthcare Conferences In September

CHRS stock is moving higher on August 21, 2019, after the company announced it was presenting at two investor healthcare conferences in September. Management will deliver a...

by Lance Jepsen

Stock Trading

August 19, 2019

Miragen Therapeutics Stock Analysts Secret Darling

Miragen Therapeutics is a stock secretly loved by quite a few analysts. Most recently, H.C. Wainwright. On August 19, 2019, H.C. Wainwright analyst Vernon Bernardino initiated...

by Lance Jepsen

Stock Trading

August 19, 2019

Nabriva Therapeutics Stock FDA Decision Hours Away

An FDA decision may be hours away for Nabriva Therapeutics stock. The FDA PDUFA date for Nabriva Therapeutics Lefamulin (oral & IV) is set for August 19, 2019. On August...

by Lance Jepsen

Business

August 14, 2019

Novavax Stock Up 21 Percent On HC Wainwright Hike

Novavax stock price has rocketed up 21 percent after H.C. Wainwright analyst Vernon Bernardino raised his price target from $10 to $17. Mr. Bernardino likes the agreement on a...

by Lance Jepsen

Stocks To Watch

August 6, 2019

T2 Biosystems Stock Moving After Medicare & Medicaid Services Approval

T2 Biosystems stock is moving after the company announced today that the United States Centers for Medicare & Medicaid Services (CMS) granted approval for a New...

by Lance Jepsen

« Older Articles